AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $50.38M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.57pm 28/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 15.5¢ | Day High | 16.5¢ | Day Low | 15.5¢ | |||
| Daily Volume | 45781 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 14.0¢ | 35714 | 0 | 16.5¢ | 153216 | |
Directors & Senior Management
| Ms. Amanda Jones | Company Secretary |
| Mr. Andrew Bloore | Non-Executive Deputy Chair |
| Mr. Bertus Strydom | Group Chief Financial Officer |
| Ms. Joanne Barber | Chief Human Resources Officer |
| Mr. Kelvin Robert Ryan | Special Advisor |
| Mr. Mark Simonds | Executive Director of Design, Procurement & Construction and Executive Director |
| Hon. Michael Sukkar | Independent Non-Executive Director |
| Mr. Piers O'Brien | Non-Executive Director |
| Mr. Rhett Simonds | Group CEO & Executive Chairman |
| Mr. Richard John Grellman | Independent Non-Executive Director |
| Mr. Vallence Gary Simonds | Founder & Senior Company Advisor |
Data source: ADVFN
